Oliver Schnell Selected Research

Obesity Management

1/2023	New insights into the treatment of obesity.
1/2022	Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Schnell Research Topics

Disease

37	Type 2 Diabetes Mellitus (MODY) 12/2023 - 12/2002
33	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2007
29	Neoplasms (Cancer) 02/2024 - 07/2006
24	Glioma (Gliomas) 03/2024 - 06/2006
15	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 07/2002
14	Heart Failure 03/2024 - 09/2013
11	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 12/2005
6	Myocardial Infarction 01/2023 - 12/2007
6	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 11/2011
6	Hyperglycemia 01/2020 - 11/2008
5	Chronic Renal Insufficiency 03/2024 - 01/2021
5	Hypoxia (Hypoxemia) 03/2024 - 01/2010
5	Diabetes Mellitus 11/2023 - 07/2002
5	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2010
4	Obesity 03/2024 - 07/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 05/2015
4	Body Weight (Weight, Body) 01/2023 - 05/2016
4	Meningioma (Meningiomas) 04/2022 - 01/2018
4	COVID-19 01/2022 - 01/2020
4	Weight Gain 03/2020 - 06/2009
3	Disease Progression 02/2024 - 09/2014
3	Astrocytoma (Pilocytic Astrocytoma) 02/2024 - 07/2011
3	Hypertension (High Blood Pressure) 01/2023 - 07/2012
3	Albuminuria 01/2023 - 09/2022
3	Weight Loss (Weight Reduction) 01/2023 - 10/2020
3	Diabetes Complications 05/2014 - 10/2009
2	Peripheral Arterial Disease 01/2024 - 02/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2020
2	Stroke (Strokes) 01/2023 - 01/2022
2	Oligodendroglioma 05/2022 - 07/2011
2	Residual Neoplasm 01/2022 - 03/2015
2	Insulin Resistance 01/2022 - 01/2017
2	Overweight 01/2022 - 01/2022
2	Death (Near-Death Experience) 01/2020 - 09/2013
2	Inflammation (Inflammations) 09/2019 - 08/2004
2	Fibrosis (Cirrhosis) 09/2019 - 07/2012
2	Coronary Disease (Coronary Heart Disease) 04/2014 - 09/2013
2	Glucose Intolerance 04/2014 - 09/2013
2	Acute Coronary Syndrome 01/2006 - 12/2005

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 12/2005
26	Insulin (Novolin)FDA Link 01/2023 - 12/2002
14	Blood Glucose (Blood Sugar)IBA 01/2022 - 09/2007
10	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 07/2012
9	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2024 - 01/2020
8	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 01/2020
6	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2021
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024 - 07/2011
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 07/2011
6	Peptides (Polypeptides)IBA 01/2023 - 07/2008
6	Hypoglycemic Agents (Hypoglycemics)IBA 06/2016 - 11/2008
5	SodiumIBA 10/2023 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 08/2022 - 12/2007
5	Acarbose FDA LinkGeneric 05/2016 - 01/2010
4	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 10/2022
4	IntegrinsIBA 06/2018 - 07/2008
4	C-Reactive ProteinIBA 07/2013 - 08/2004
3	Glucagon-Like Peptide-1 ReceptorIBA 10/2023 - 01/2023
3	tirzepatideIBA 10/2023 - 01/2023
3	finerenoneIBA 10/2023 - 09/2022
3	Lomustine (CCNU)FDA Link 01/2022 - 01/2019
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 07/2013
3	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2020 - 12/2014
3	CytokinesIBA 11/2019 - 01/2019
3	MethyltransferasesIBA 01/2018 - 12/2007
3	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2016
2	semaglutideIBA 03/2024 - 01/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 10/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2023 - 01/2023
2	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 11/2021
2	Protein Subunit VaccinesIBA 05/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 05/2022 - 02/2019
2	B7-H1 AntigenIBA 05/2022 - 09/2017
2	LDL CholesterolIBA 02/2022 - 01/2017
2	Meclofenamic Acid (Meclofenamate)FDA LinkGeneric 01/2022 - 11/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 11/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 12/2014
2	Pioglitazone (Actos)FDA Link 01/2020 - 06/2013
2	RNA (Ribonucleic Acid)IBA 11/2019 - 02/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 10/2016
2	Epidermal Growth Factor (EGF)IBA 02/2017 - 03/2015
2	Glycoside Hydrolase InhibitorsIBA 05/2016 - 07/2012
2	Alkylating AgentsIBA 09/2012 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 12/2007
2	Integrin beta3 (GPIIIa)IBA 12/2009 - 07/2008
2	Integrin alphaVbeta3IBA 12/2009 - 07/2008
2	Hemoglobins (Hemoglobin)IBA 10/2009 - 11/2008
2	AmmoniaIBA 12/2002 - 07/2002
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2002 - 07/2002
2	Nitrogen-13IBA 12/2002 - 07/2002

Therapy/Procedure

42	Therapeutics 09/2023 - 08/2004
15	Radiotherapy 11/2023 - 04/2011
14	Drug Therapy (Chemotherapy) 01/2023 - 07/2011
11	Glycemic Control 11/2023 - 06/2009
6	Chemoradiotherapy 01/2023 - 09/2014
4	Immunotherapy 05/2022 - 06/2017
3	Re-Irradiation 01/2022 - 12/2012
3	Contraindications 10/2020 - 12/2012
2	Obesity Management 01/2023 - 01/2022
2	Palliative Care (Palliative Therapy) 01/2020 - 09/2013
2	Adjuvant Radiotherapy 11/2019 - 01/2018